Transcatheter Market Research Report: By Type of Treatment (Transfemoral Approach, Transapical Approach, and Others), by Product Type (TAVR and TMVR), by End-User (Hospitals, Ambulatory Surgical Centers, Others), and by Region-Forecast Till 2027
ID: MRFR/MED/4757-CR | July 2018 | Region: Global | 100 pages
Transcatheter Market Overview:
The transcatheter market is expected to grow from USD 3,882.77 Mn in 2017 to more than USD 8,190 Mn by 2023-end.
Due to following a hectic lifestyle, the occurrence and recurrence of cardiovascular ailments have amplified throughout the whole world. Additionally, the commonality of hypertension, which is considered to be the prime cause of congestive heart failure and cardiac arrest, has been increasing as well.
Thus, to treat these potentially life-threatening health conditions, the demand for minimally-invasive treatment options is growing as well. According to the experts, this massive demand for the same will prompt the colossal growth of the global Transcatheter Market during the projected forecast period.
COVID-19 Analysis of Transcatheter Market:
The unforeseen emergence of the COVID-19 pandemic has imposed negatively on the Transcatheter market, especially during the initial stage of the lockdown. Thus, the substantial growth of the same was thwarted for a specific period. Additionally, the resurgence of the endemic had also affected the availability of cardiac surgeons to some extent in the wake of pandemic-based restrictions. It, sequentially, affected the market growth as well. Nevertheless, during the latter half of 2020, the market for medical equipment began intensifying again owing to the distinctive symptoms of COVID-19. Due to the lack of awareness, many COVID-19 patients did not get treated within the initial stage.
It, successively, prompted the disease to infiltrate through the heart and cause cardiovascular complications. As a result, the reliance on the Transcatheter increased even more. Apparently, the sudden growth of dependence instinctively resulted in a rapid expansion of the Transcatheter Market as well. Furthermore, there is also a slight change that has been evident in the health equipment market. The manufacturers of the same are pouncing on the same and creating strategic moves to assimilate a remedial step in their offerings. According to experts, it might drive the growth of the market even further in the near future as well.
Transcatheter Market Dynamics:
Major Drivers of the Transcatheter Market
The prominence in the prevalence of mitral valve disorder and other major cardiovascular diseases has been amplifying since the last decade. As per the lifestyle experts, the commonness of the same will increase even more during the upcoming years due to lifestyle-related problems. The Transcatheter module, in essence, is primarily used for treating heart-related conditions. Hence, the ever-rising number of cardiovascular can be considered as the major driving factor in the uprising of the Transcatheter aortic valve replacement market size.
- Opportunities
Previously, the growth of the transcatheter market size for Transcatheter aortic valve was more prominent in western countries. However, due to its overall efficiency regarding aortic valve treatment, more and more countries throughout the world are attempting to implement it. It, sequentially, can give a substantial boost to the market growth and prompt it to expand in a desirable manner. Furthermore, integrating various changes (such as equipment or medication) in the same can improve the effectiveness of the medical approach and increase its demand among patients.
- Restraints
The Transcatheter aortic valve replacement is, in essence, a minimally-invasive medical procedure, which is used to replace the aortic valve of the patient. It is done so without the removal of the damaged or older valve. The whole modus operandi of the medical procedure is already quite well-developed and –designed. However, there are still some issues regarding the same available, which can restrain the growth of the Transcatheter aortic valve implantation market. Amongst them, the difficulty of the procedure is considered to be quite prevalent. The medical process, in essence, is quite intricate and, therefore, is prone to failure. Thus, many patients tend to choose the safer options in this aspect. Furthermore, there is no surety that the procedure can be effective for the individual for over ten years. It is yet another aspect, which might prevent an individual to avoid it.
- Challenges
The occurrence of the calamitous COVID-19 pandemic had imposed an abrupt halt in the growth of the Transcatheter Market. So, it can continue to be a threat of the same during the later years as well. Furthermore, the overall cost of the procedure is quite high as well. It can also prompt the patients, who belong to the middle-class segment, to avoid the same. This specific challenge can pose to affect the transcatheter market for a prolonged period.
- Cumulative Growth Analysis
The approximate growth percentage of the Transcatheter aortic valve implantation market has been recorded at 14.4%. The expansion of the same will excel even more during the latter years and reach the market of $4.67 billion by the year of 2027. The values provided here are based on the current and rising demand for the procedure. It might increase or decrease depending on the strata of the market in the near future. However, the end result will not be much different from the provided expectation at all.
Value Chain Analysis of Transcatheter Market:
Having thorough know-how about the value chain of the Transcatheter heart valve market is imperative to perceive its growth potential. The uprising in the worth of the aforementioned market primarily depends on the usage of technology during the procedure. In the upcoming years, the development and prominence of the same will improve exponentially. Thus, the value of the transcatheter market is also anticipated to increase massively alongside the same.
Transcatheter Market Segment Overview:
The global Transcatheter Market can be segmented by the type of treatment procedure and the end-user.
- By Type
By the type of treatment, the Transcatheter heart valve market is segmented into the transapical approach, transaortic approach, and transfemoral approach. Amongst these, the transfemoral approach is anticipated to lead the market during the forecast period due to the sudden increase in the prominence of valvular diseases.
The vulnerability to cardiovascular ailments among the geriatric population can prompt its growth as well. Conversely, the transaortic segment will predictably depict a stern CAGR rating owing to the frequent usage of the aorta cannulation procedure during ongoing cardiac surgeries.
- By End-User
The end-users in the Transcatheter heart valve replacement market include – the ambulatory surgical center, cardiac catheterization laboratory, and hospital. Amidst them, the hospitals are considered to be the largest end-user of the Transcatheter procedure.
Thus, it will bring in the highest amount of revenue as well. The reasons for such a massive growth can be credited to the patient volume, the profusion of equipment and skilled surgeon, and various insurance schemes covering up the medical procedures.
Transcatheter Market Regional Analysis:
North America to Grow Exponentially During the Forecast Period:
The regional segment for the global Transcatheter Market can be categorized into – North America, South America, Asia, Europe, and Middle East & Africa. Amongst them, North America currently holds the largest share of the market owing to the contributions of Canada and the USA. The utter prevalence of the well-established medical sector along with the prevalence of cardiovascular disease will prompt growth in this region. Aside from NA, Europe will experience the same amount of growth due to similar reasons like the USA.
Transcatheter Market Competitive Landscape:
The Meril Life Sciences PVT. LTD is considered to be one of the key players in the competitive landscape of the Transcatheter market. The organization is primarily known for its innovativeness while creating the necessary equipment regarding the procedure.
The Boston Scientific Corporation is one of the major manufacturers of the implanted devices and coronary stents. They tend to operate through a more direct marketing procedure and create simplified devices to hold the leading position firmly.
The list of key companies covered in the report is -
- Edwards Lifesciences Corporation
- JenaValve Technology, Inc
- Terumo Corporation
- Neovasc Inc.
- Edwards Lifesciences Corporation
Transcatheter Market Recent Developments:
- The MitraClip has become the first and the only FDA-cleared device in the current scenario.
- The Transcatheter Mitral Valves are working towards a proper market clearance.
- In 2018, Abbott initiated a clinical summit on the Treatment of Symptomatic Mitral Regurgitation.
- In 2017, Medtronic renounced the implantation of the Intrepid TMVR System on the first patient in the world.
Transcatheter Market Report Overview
The report overview of the same is as follows –
- Overview of the market
- COVID 19 analysis
- Dynamics of the market
- Value chain analysis
- Market segmentation
- Regional analysis
- Competitive analysis
- Recent Developments of the key players
The scope of the report is to provide clarity on the subject of the Transcatheter market’s potential growth and highlights its overall strengths. Moreover, it also aims to provide a subtle amount of information on the key players of the transcatheter market .
Transcatheter Market Segmentation Table”
By Type
- Transapical approach
- Transaortic approach
- transfemoral approach
By End-User
- Ambulatory surgical center
- Cardiac catheterization laboratory
- Hospital
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2023: USD 8,190 Mn |
| CAGR | 2018-2023: Substantial CAGR |
| Base Year | 2019 |
| Forecast Period | 20227 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type Of Treatment Procedure and The End-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Edwards Lifesciences Corporation, JenaValve Technology, Inc, Terumo Corporation, Neovasc Inc., Edwards Lifesciences Corporation |
| Key Market Opportunities | Efficiency Regarding Aortic Valve Treatment |
| Key Market Drivers | the massive prevalence of chronic cardiovascular disease, minimally invasive medical procedures, and the ever-growing preference for the Transcatheter process. |
Frequently Asked Questions (FAQ) :
The North American region will grow the most during this period. However, a similar form of growth can be seen for the European continent as well.
Transcatheter market would reach up to a valuation of USD 8190 million.
What would be the projected CAGR of the transcatheter market during the forecast period (2020-2027)?
Transcatheter market would attain a CAGR of 13.38% during the forecast period of 2020 to 2027.
The TAVR segment has control of the transcatheter market.
The transcatheter market includes segments like hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratory.
The Transcatheter Market will grow at a CAGR of 14.4% by 2027.
The prime driving factors of the market are – the massive prevalence of chronic cardiovascular disease, minimally invasive medical procedures, and the ever-growing preference for the Transcatheter process.
1 Executive Summary
2 Market Introduction
2.1 Scope Of The Study 16
2.2 Research Objective 16
2.3 List Of Assumptions 16
2.4 Market Structure 17
3 Research Methodology
3.1 Research Process 19
3.2 Primary Research 20
3.3 Secondary Research 21
3.4 Market Size Estimation 22
3.5 Forecast Model 22
4 Market Dynamics
4.1 Drivers 24
4.1.1 Introduction 24
4.1.2 Increase In Preference For Minimally Invasive Procedures 25
4.1.3 Increasing Prevalence Of Cardiovascular Diseases 26
4.1.4 Favorable Reimbursement Policies 27
4.2 Restraints 28
4.2.1 Strict Regulatory Guidelines 28
4.2.2 Risk Of Infection 28
4.3 Opportunities 29
4.3.1 New Advancements In Novel Cardiac Catheterization Devices 29
5 Market Factor Analysis
5.1 Value Chain Analysis 31
5.1.1 R&D And Designing 31
5.1.2 Manufacturing 31
5.1.3 Distribution & Sales 31
5.1.4 Post-Sales Monitoring 32
5.2 Porter’s Five Forces Model 32
5.2.1 Bargaining Power Of Suppliers 32
5.2.2 Bargaining Power Of Buyers 33
5.2.3 Threat Of New Entrants 33
5.2.4 Threat Of Substitutes 33
5.2.5 Intensity Of Rivalry 33
5.3 Demand & Supply: Gap Analysis 34
5.4 Pricing Analysis 34
6 Transcatheter Market, By Type Of Treatment
6.1 Overview 36
6.1.1 Transfemoral Approach 37
6.1.2 Transapical Approach 37
6.1.3 Transaortic Approach 38
7 Transcatheter Market, By Product Type
7.1 Introduction 40
7.1.1 Transcatheter Aortic Valve Replacement (TAVR) 41
7.1.2 Transcatheter Mitral Valve Repair (TMVR) 41
8 Transcatheter Market, By End User
8.1 Introduction 43
8.1.1 Hospitals 44
8.1.2 Ambulatory Surgical Centres (ASCs) 44
8.1.3 Cardiac Catheterization Laboratory 44
9 Global Transcatheter Market, By Region
9.1 Introduction 46
9.2 Americas 47
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.2.1 North America 48
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.2.1.1 U.S. 49
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.2.1.2 Canada 50
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.2.2 South America 51
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.3 Europe 53
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.3.1 Germany 55
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.3.2 U.K 56
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.3.3 France 57
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.3.4 Spain 58
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.3.5 Italy 59
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.3.6 Rest Of Europe 60
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.4 Asia Pacific 61
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.4.1 China 63
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.4.2 Japan 64
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.4.3 India 65
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.4.4 Australia 66
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.4.5 Rest Of Asia Pacific 67
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.5 Middle East & Africa 68
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.5.1 Middle East 70
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
9.5.2 Africa 71
Transcatheter Market, By Type Of Treatment
Transcatheter Market, By Product Type
Transcatheter Market, By End User
10 Company Landscape
10.1 Company Market Share Analysis 73
10.1.1 Introduction 73
10.2 Competitive Landscape 74
10.2.1 Introduction 74
10.3 Key Developments 75
11 Company Profiles
11.1 Edwards Lifesciences Corporation 78
11.1.1 Company Overview 78
11.1.2 Financial Overview 78
11.1.3 Products Offering 79
11.1.4 Key Developments 79
11.1.5 SWOT Analysis 79
11.1.6 1.1.6 Key Strategy 79
11.2 Meril Life Sciences Pvt. Ltd. 80
11.2.1 1.2.1 Company Overview 80
11.2.2 Financial Overview 80
11.2.3 Products Offering 80
11.2.4 Key Developments 80
11.2.5 1.2.5 SWOT Analysis 80
11.2.6 Key Strategy 80
11.3 Braile Biomedica 81
11.3.1 1.3.1 Company Overview 81
11.3.2 Financial Overview 81
11.3.3 Products Offering 81
11.3.4 Key Developments 81
11.3.5 SWOT Analysis 81
11.3.6 Key Strategy 81
11.4 Venus Medtech 82
11.4.1 1.4.1 Company Overview 82
11.4.2 Financial Overview 82
11.4.3 Products Offering 82
11.4.4 Key Developments 82
11.4.5 Key Strategy 83
11.5 Boston Scientific Corporation 84
11.5.1 Company Overview 84
11.5.2 Financial Overview 84
11.5.3 Products Offering 85
11.5.4 Key Developments 85
11.5.5 Key Strategy 85
11.6 JenaValve Technology, Inc. 86
11.6.1 Company Overview 86
11.6.2 Financial Overview 86
11.6.3 Products Offering 86
11.6.4 Key Developments 86
11.6.5 SWOT Analysis 87
11.6.6 Key Strategy 87
11.7 Abbott Laboratories 88
11.7.1 Company Overview 88
11.7.2 Financial Overview 88
11.7.3 Products Offering 89
11.7.4 Key Developments 89
11.7.5 SWOT Analysis 89
11.7.6 1.7.6 Key Strategy 89
11.8 Medtronic PLC 90
11.8.1 Company Overview 90
11.8.2 Financial Overview 90
11.8.3 Products Offering 91
11.8.4 Key Developments 91
11.8.5 SWOT Analysis 91
11.8.6 Key Strategy 91
11.9 Bracco Diagnostic Inc. 92
11.9.1 Company Overview 92
11.9.2 Financial Overview 92
11.9.3 Products Offering 92
11.9.4 Key Developments 92
11.9.5 SWOT Analysis 93
11.9.6 Key Strategy 93
11.10 Cook Medical Inc. 94
11.10.1 Company Overview 94
11.10.2 Financial Overview: 94
11.10.3 Products Offering 94
11.10.4 Key Developments 94
11.10.5 SWOT Analysis 95
11.10.6 Key Strategy 95
12 Appendix
12.1 Discussion Blue Print 97
12.2 Reference 99
13 List Of Tables
TABLE 1 MARKET SYNOPSIS 14
TABLE 2 LIST OF ASSUMPTIONS 16
TABLE 3 PRIMARY INTERVIEWS 19
TABLE 4 GLOBAL TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 36
TABLE 5 GLOBAL TRANSCATHETERSS MARKET FOR TRANSFEMORAL APPROACH, BY REGION 2020-2027 (USD MILLION) 37
TABLE 6 GLOBAL TRANSCATHETERSS MARKET FOR TRANSAPICAL APPROACH, BY REGION 2020-2027 (USD MILLION) 37
TABLE 7 GLOBAL TRANSCATHETERSS MARKET FOR TRANSAORTIC APPROACH, BY REGION 2020-2027 (USD MILLION) 38
TABLE 8 GLOBAL TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 40
TABLE 9 GLOBAL TRANSCATHETERSS MARKET FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR), BY REGION 2020-2027 (USD MILLION) 41
TABLE 10 GLOBAL TRANSCATHETERSS MARKET FOR TRANSCATHETER MITRAL VALVE REPAIR (TMVR), BY REGION 2020-2027 (USD MILLION) 41
TABLE 11 GLOBAL TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 43
TABLE 12 GLOBAL TRANSCATHETERSS MARKET FOR HOSPITALS, BY REGION 2020-2027 (USD MILLION) 44
TABLE 13 GLOBAL TRANSCATHETERSS MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION 2020-2027 (USD MILLION) 44
TABLE 14 GLOBAL TRANSCATHETERSS MARKET FOR CARDIAC CATHETERIZATION LABORATORY, BY REGION 2020-2027 (USD MILLION) 44
TABLE 15 GLOBAL TRANSCATHETER MARKET, BY REGION 2020-2027 (USD MILLION) 46
TABLE 16 AMERICAS TRANSCATHETER MARKET, BY REGION 2020-2027 (USD MILLION) 47
TABLE 17 NORTH AMERICA TRANSCATHETER MARKET, BY COUNTRY 2020-2027 (USD MILLION) 48
TABLE 18 NORTH AMERICA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 48
TABLE 19 NORTH AMERICA TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 49
TABLE 20 NORTH AMERICA TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 49
TABLE 21 U.S. TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 49
TABLE 22 U.S. TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 50
TABLE 23 U.S. TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 50
TABLE 24 CANADA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 50
TABLE 25 CANADA TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 51
TABLE 26 CANADA TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 51
TABLE 27 SOUTH AMERICA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 51
TABLE 28 SOUTH AMERICA TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 52
TABLE 29 SOUTH AMERICA TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 52
TABLE 30 EUROPE TRANSCATHETER MARKET, BY COUNTRY 2020-2027 (USD MILLION) 53
TABLE 31 EUROPE TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 54
TABLE 32 EUROPE TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 54
TABLE 33 EUROPE TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 54
TABLE 34 GERMANY TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 55
TABLE 35 GERMANY TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 55
TABLE 36 GERMANY TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 55
TABLE 37 U.K TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 56
TABLE 38 U.K TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 56
TABLE 39 U.K TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 56
TABLE 40 FRANCE TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 57
TABLE 41 FRANCE TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 57
TABLE 42 FRANCE TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 57
TABLE 43 SPAIN TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 58
TABLE 44 SPAIN TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 58
TABLE 45 SPAIN TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 58
TABLE 46 ITALY TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 59
TABLE 47 ITALY TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 59
TABLE 48 ITALY TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 59
TABLE 49 REST OF EUROPE TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 60
TABLE 50 REST OF EUROPE TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 60
TABLE 51 REST OF EUROPE TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 60
TABLE 52 ASIA PACFIC TRANSCATHETER MARKET, BY COUNTRY 2020-2027 (USD MILLION) 61
TABLE 53 ASIA PACIFIC TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 62
TABLE 54 ASIA PACIFIC TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 62
TABLE 55 ASIA PACIFIC TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 63
TABLE 56 CHINA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 63
TABLE 57 CHINA TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 63
TABLE 58 CHINA TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 64
TABLE 59 JAPAN TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 64
TABLE 60 JAPAN TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 64
TABLE 61 JAPAN TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 65
TABLE 62 INDIA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 65
TABLE 63 INDIA TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 65
TABLE 64 INDIA TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 66
TABLE 65 AUSTRALIA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 66
TABLE 66 AUSTRALIA TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 66
TABLE 67 AUSTRALIA TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 67
TABLE 68 REST OF ASIA PACIFIC TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 67
TABLE 69 REST OF ASIA PACIFIC TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 67
TABLE 70 REST OF ASIA PACIFIC TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 68
TABLE 71 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY COUNTRY 2020-2027 (USD MILLION) 68
TABLE 72 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 69
TABLE 73 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 69
TABLE 74 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 69
TABLE 75 MIDDLE EAST TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 70
TABLE 76 MIDDLE EAST TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 70
TABLE 77 MIDDLE EAST TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 70
TABLE 78 AFRICA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020-2027 (USD MILLION) 71
TABLE 79 AFRICA TRANSCATHETER MARKET, BY PRODUCT TYPE 2020-2027 (USD MILLION) 71
TABLE 80 AFRICA TRANSCATHETER MARKET, BY END USER 2020-2027 (USD MILLION) 71
TABLE 81 GLOBAL TRANSCATHETERS MARKET: KEY DEVELOPMENT 75
14 List Of Figures
FIGURE 1 GLOBAL TRANSCATHETER MARKET: MARKET STRUCTURE 17
FIGURE 2 RESEARCH PROCESS 19
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 22
FIGURE 4 VALUE CHAIN: TRANSCATHETER MARKET 31
FIGURE 5 PORTERS FIVE FORCES MODEL 32
FIGURE 6 GLOBAL TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2020 & 2027 (USD MILLION) 37
FIGURE 7 GLOBAL TRANSCATHETER MARKET, BY PRODUCT TYPE 2020 & 2027 (USD MILLION) 40
FIGURE 8 GLOBAL TRANSCATHETER MARKET, BY END USER 2020 & 2027 (USD MILLION) 43
FIGURE 9 GLOBAL TRANSCATHETER MARKET, BY REGION 2020 & 2027 (USD MILLION) 46
FIGURE 10 AMERICAS TRANSCATHETER MARKET, BY REGION 2020 (%) 47
FIGURE 11 NORTH AMERICA TRANSCATHETER MARKET, BY COUNTRY 2020 (%) 48
FIGURE 12 EUROPE TRANSCATHETER MARKET, BY COUNTRY 2020 (%) 53
FIGURE 13 ASIA PACFIC TRANSCATHETER MARKET, BY COUNTRY 2020 & 2027 (%) 62
FIGURE 14 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY COUNTRY 2020 & 2027 (%) 69
FIGURE 15 GLOBAL TRANSCATHETERS MARKET, MARKET SHARE ANALYSIS 2020 (%) 73
FIGURE 16 GLOBAL TRANSCATHETERS MARKET COMPETITIVE LANDSCAPE (%) 74
Global Transcatheter Market: Competitive Landscape
Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, and Abbott Laboratories Inc. accounted for approximately 52% share of the global transcatheter market in 2017. These companies continue to retain their strong global presence through expansions, mergers and acquisitions, and extensive product portfolio.
Edwards Lifesciences Corporation is an American company known for manufacturing heart valve systems and repair products. The company’s transcatheter heart valve therapy and surgical heart valve therapy products are manufactured in the US, Singapore, and Switzerland. The company’s subsidiaries include Edwards Lifesciences Asset Management Corporation, Edwards Lifesciences CardiAQ LLC., Valtech Cardio Inc., and Red Hill Insurance Corporation.
Medtronic plc accounted for the second largest market share of the global transcatheter market owing to the innovation of less-invasive, miniaturized, and Mechanical Circulatory Support (MCS) technologies for treating patients with advanced heart failure. The company has the ability to create meaningful innovations for hospitals, health systems, and healthcare providers and the ability to deliver the best care possible to patients around the world.
Boston Scientific Corporation is the developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company held the third position in terms of market share in 2017. It is dedicated to collaborating with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, increase efficiencies, and most importantly, help people around the world to live longer and healthier. Boston Scientific offers a wide range of products categorized as featured products, medical specialty, and many others.
Medtronic, Inc. manufactures and sells device-based medical therapies. The company manufactures image-guided surgery and intra-operative imaging systems. Its products include electrophysiology catheters implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain and other disorders.
Abbott Laboratories Inc. has a significant product portfolio which focuses on discovery, development, manufacturing, and sales of healthcare products. The company operates through four reportable segments, namely, established pharmaceutical products, diagnostic products, nutritional products, and vascular products. Furthermore, the company has two non-reportable segments, namely, diabetes care and medical optics. The diabetes care division of the company is located in California, US and provides blood glucose meters, blood glucose test strips, sensors, data management decision software, and accessories. The company manufactures its blood glucose test strips at Witney, UK site.
The global transcatheter market is a promptly growing market and involves the manufacturing of various types of transcatheter for different cardiovascular procedures. Hence, the market is not completely dominated by any one or two players but is fairly divided among the top transcatheter’ manufacturing companies. Many leading players are focusing on the American and European markets owing to well-established markets, huge patient population, and high healthcare expenditures. These players have expanded their market in other regions as well. Major companies have a huge brand identity and product portfolio. These companies have adopted the organic strategy of product launches and acquisitions to gain the market.